Interaction of human dihydroorotate dehydrogenase with ubiquinone in model lipid bilayers
Human dihydroorotate dehydrogenase (DHODH) is an integral membrane protein involved in pyrimidine biosynthesis. DHODH is a well-validated target for anti-inflammatory and anti-proliferative drugs that act as inhibitors. Mutations in DHODH cause Miller syndrome, a rare genetic disorder. DHODH contains two amphipathic alpha helices proposed to be critical for its interaction with the membrane, with its co-substrate ubiquinone Q10 and with inhibitors. Our goal is to investigate the mechanisms by which these interactions occur in a physiologically relevant membrane-bound state consisting of oriented planar lipid bilayers using neutron reflectivity. We have previously performed a successful experiment to investigate the formation and structure of lipid bilayers containing ubiquinone Q10 and a shorter derivative (ubiquinone Q2). As a continuation, we propose to investigate the interaction of N-terminally truncated DHODH (consisting of the catalytic domain and membrane-binding helices) with lipid bilayers containing either ubiquinone Q2 or Q10.
Please note that you will need to login with your ILL credentials to download the data.
Download DataThe recommended format for citing this dataset in a research publication is in the following format:
OROZCO RODRIGUEZ Juan Manuel; BOGOJEVIC Oliver; DELHOM Robin; FRAGNETO Giovanna; KNECHT Wolfgang and WACKLIN KNECHT Hanna. (2019). Interaction of human dihydroorotate dehydrogenase with ubiquinone in model lipid bilayers. Institut Laue-Langevin (ILL) doi:10.5291/ILL-DATA.8-02-821